Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Potlatch Posts Q4 Profit

RELATED NEWS
Trade PCH now with 

Potlatch Corp. (PCH: Quote) Tuesday said it turned to profit in the fourth quarter, as its wood products segment experienced a real turnaround in its markets, with strong demand for manufactured wood products resulting in sharply higher prices.

The company reported a profit of $13.9 million or $0.34 per share for the quarter, compared to a loss of $1.5 million or $0.04 per share in the same period last year.

On average, eight analysts polled by Thomson Reuters expected the company to earn $0.32 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues increased to $143.30 million from $109.30 million last year. Analysts expected revenues of $136.83 million.

Click here to receive FREE breaking news email alerts for Potlatch Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.